Good News For Senseonics, Medtronic Diabetes Devices

US FDA recently approved the first 90-day CGM system and expanded the labeling for a closed-loop system to treat diabetes.

US FDA has green-lighted two diabetes products in recent days that could have significant impact in the sector, including a long-use continuous glucose meter that the agency says gives patients more control of their lives, and an expanded indication for a closed-loop system for younger patients.

On June 21, FDA approved Senseonics Holdings Inc.'s 90-day inserted Eversense CGM system. The agency says it's the first...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation